glp-1 generic drugs FDA Approves Hikma's Version of Diabetes Drug Victoza Will Generic GLP-1 Drugs Change
Description
Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
Therefore, there is a need to identify those potential changes and adjust patients medication doses in order to achieve higher efficacy and avoid toxicity.
The results of a Phase II clinical trial have demonstrated significant weight reduction in overweight and obese adults
Although dedicated trials of GLP-1RAs in AITD are lacking, preliminary reports suggest potential impacton thyroid volume, thyroid function, and autoimmune activity
